Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9396245 | Transplantation Proceedings | 2005 | 4 Pages |
Abstract
Specimens with all of above-mentioned findings were categorized as severe ABO-AMHR; those with at least one findings, were categorized as mild ABO-AMHR. All patients were treated with steroid pulse therapy and/or modification of other immunosuppressants. Group 1 consisted of severe ABO-AMHR (n = 6); group 2 consisted of mild ABO-AMHR (n = 5); group 3 consisted of acute cellular rejection (n = 3); group 4 consisted of recovery phase of ATN (n = 11); group 5 consisted of calcineurin inhibitor toxicity (n = 2); and group 6 consisted of normal histology (n = 5). One of 6 patients (16%) in group 1 lost the graft because of DHAR irreversible by antirejection and anticoagulation therapy. However, there has been no clear definition of histpathological criteria for DHAR after ABO-incompatible kidney transplantation. The definition must prognosticate whether the rejection process is reversible.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
K. Sugiyama, K. Arai, A. Aikawa, M. Miyagi, T. Ohara, A. Hasegawa, M. Muramatsu, N. Hirayama, E. Tajima, T. Kawamura, H. Ogihara, T. Hadano, H. Nakano,